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TO THE EDITOR
Atopic dermatitis (AD) represents a
chronic manifestation of allergic skin
inflammation (Bieber, 2008; Werfel,
2009). IgE- and T cell-mediated auto-
reactivity has been shown to contribute
to the disease pathomechanism in AD
(Schmid-Grendelmeier et al., 2005;
Zeller et al., 2009; Heratizadeh et al.,
2011). a-NAC (the alpha-chain of the
nascent polypeptide–associated complex;
Hom s 2) is an intracellular chaperone
and one of the few IgE-reactive autoanti-
gens that have been directly isolated by
the screening of a human complementary
DNA library with serum from a patient
suffering from severe AD. a-NAC has
been shown to have high IgE reactivity
comparable to other classical allergens
(Natter et al., 1998; Mossabeb et al.,
2002). We could show earlier that
a-NAC induces preferential proliferation
of CLAþ T cells in vitro, suggesting a
possible role in cutaneous inflammation.
a-NAC-specific T cell clones were
generated from peripheral blood
mononuclear cells (PBMCs) of AD
patients and were predominantly of the
Th1 phenotype (Heratizadeh et al.,
2011). Moreover, Mittermann et al.
(2008) have recently shown that a-NAC
induced significantly stronger secretion of
IFN-g compared with a major exogenous
allergen (Phl p 1) in human PBMCs.
To date, it is not clear whether a-NAC
acts directly on T cells or whether other
cell populations contribute to the T cell
response. Therefore, we performed sur-
face staining of human PBMCs incu-
bated with a-NAC. As exemplified in
Figure 1a, CD14þ monocytes showed
reproducible binding of a-NAC, which
was not the case for the other PBMC
populations tested.
To see whether the binding of a-NAC
to monocytes also resulted in activation
of these cells, we analyzed the super-
natants of PBMCs and of isolated mono-
cytes for monocyte-specific cytokines.
a-NAC induced secretion and transcrip-
tion of IL-12 p40 and IL-6 in monocytes
(Figure 1b and c). IL-12 p40 secretion
and mRNA expression were significantly
higher in PBMCs than in isolated mono-
cytes (Figure 1d and e), suggesting a
cross talk between monocytes and
T cells. IL-2 increased a-NAC-mediated
IL-12 expression and secretion in PBMCs
but not in isolated monocytes (Figure
1b–d). At the transcriptional level, we
found even higher numbers of proin-
flammatory cytokines to be induced in
monocytes by a-NAC, such as IL-12
p35, IL-1A, IL-1B, IL-8, and TNF-a
(Supplementary Figure S1 online).
As not only secretion but also tran-
scription of cytokines was promoted in
a-NAC-stimulated monocytes, we ana-
lyzed signal transduction in these cells.
Corresponding to the effects on mRNA
and protein levels, both stimulation with
a-NAC alone or in combination with IL-2
led to phosphorylation of NF-kB and the
MAP-kinase p44/42 (Erk) (Figure 1f).
a-NAC has previously been described
to induce IFN-g production in
PBMCs (Mittermann et al., 2008). As
a-NAC upregulated IL-12 production
in monocytes, we sought to ascertain
whether IL-12 was required for
a-NAC-induced IFN-g production in
PBMCs. Human PBMCs, preincubated
with a blocking antibody against IL-12,
secreted significantly lower levels of
IFN-g (Figure 2a), indicating that
a-NAC-induced IL-12 is required for
a-NAC-induced IFN-g production in
human PBMCs. To further validate this,
isolated PBMCs and CD4þ T cells from
the same donors were stimulated with
a-NAC and IL-2. After 3 days, IFN-g
could only be detected in the culture
supernatants from PBMCs but not from
isolated CD4þ T cells (Figure 2b). This
result implies that monocytes have a
crucial role. IFN-g secretion could also
be induced in CD4þ T cells cultured in
the supernatants of a-NAC-stimulated
dendritic cell (DC) subtypes, such as
inflammatory dendritic epidermal cells
(IDECs), Langerhans cells (LCs), and
DCs (Supplementary Figure S2). There-
fore, the analyzed skin-resident or skin-
infiltrating DCs, such as LCs or IDECs,
respectively, may be involved in Th1
polarization when they encounter
a-NAC in inflamed skin in AD. The
ability of a-NAC to direct DC subpopu-
lations pertinent in AD to polarize a Th1
response may contribute to the shift
from Th2-polarized acute lesions to
Th1-biased chronic lesions characteristic
of AD.
It has been described before that heat-
shock proteins or nucleic acids, released
by necrotic cells, and extracellular
matrix components can serve as endo-
genous ligands of Toll-like receptors
(TLRs) and induce innate immune
responses (Sloane et al., 2010). As the
monocyte receptor for a-NAC has not
been identified and a-NAC functions as
a co-translational chaperone, we tested
whether TLR-2 blockade could reduce
the cytokine effects of a-NAC.
By pretreatment of a-NAC-stimulated
cells with a blocking antibody against
TLR-2, we were able to inhibit cytokine
induction by a-NAC in PBMCs
(Figure 2c) and monocytes (Figure 2d).
To confirm the TLR-2 dependence of theAccepted article preview online 3 April 2013; published online 9 May 2013
Abbreviations: AD, atopic dermatitis; a-NAC, the alpha-chain of the nascent polypeptide–associated
complex; DC, dendritic cell; IDEC, inflammatory dendritic epidermal cell; LC, Langerhans cell; PBMC,
peripheral blood mononuclear cell; TLR, Toll-like receptor
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cytokine effects caused by a-NAC, we
used small interfering RNA (siRNA) to
knock down TLR-2 expression in mono-
cytes. By this method, we could reduce
surface levels of TLR-2 to 50% of
untreated cells (Figure 2e), compared
to 80% with control-siRNA. The knock-
down was more pronounced in a-NAC-
stimulated cells as a-NAC upregulated
the surface levels of TLR-2. As a result,
TLR-2 knockdown monocytes produced
less IL-12 p40 than untreated cells or
cells treated with control-siRNA after
stimulation with a-NAC (Figure 2f), con-
firming TLR-2 dependence.
– α-NAC incubation
103
103
102
102
101
101
100
100 103102101100
+ α-NAC incubation
M
ed
N
AC
N
AC
 +
IL
-2
IL
-2NAC+ CD14+ : 12.84%A–+NAC+ CD14+ : 1.79%
NAC–APC
IL-12 p40 in monocyte supernatants
600
600
800
1,000
n =10 n =6
n =8n =7
n =13 n =7
**
**
**
**
400
400
IL
-1
2 
p4
0 
(pg
/m
l)
IL
-6
 (p
g/m
l)
200
200
0 0
60,000
40,000
1,500
1,000
500
0
1,500
2,000
IL
-1
2 
p4
0 
(pg
/m
l)
1,000
500
0
20,000
N
or
m
al
iz
ed
 ra
tio
 o
f m
RN
A
N
or
m
al
iz
ed
 ra
tio
 o
f m
RN
A
N
or
m
al
iz
ed
 ra
tio
 o
f m
RN
A
0
Me
d
NA
C
NA
C+
IL-
2
IL-
2
Me
d
NA
C
NA
C+
IL-
2
IL-
2
Me
d
NA
C
NA
C+
IL-
2
IL-
2
Me
d
NA
C
NA
C+
IL-
2
IL-
2
Me
d
NA
C
NA
C+
IL-
2
IL-
2
Me
d
NA
C
NA
C+
IL-
2
IL-
2
IL-6 in monocyte supernatants
IL-6 mRNA in monocytesIL-12 p40 mRNA in monocytes
NAC–APC
CD
14
–F
IT
C
103
102
101
100
CD
14
–F
IT
C
A–+
A+– A+–A– – A– –
P-NF-κB
P-p44/42
GAPDH
IL-12 p40 in PBMC and monocyte
supernatants
IL-12 p40 mRNA in PBMCs
and monocytes
0
100
200
300
5,000
10,000
15,000
*
*
*
**
**
*
*
*
Figure 1. a-NAC (the alpha-chain of the nascent polypeptide–associated complex) binds to and activates monocytes. Peripheral blood mononuclear cells
(PBMCs) were incubated for 30 minutes with a-NAC and then stained with biotin-coupled rabbit a-NAC antibodies, detected by streptavidin-allophycocyanin
(APC), and FITC-coupled mouse antibodies against CD14, CD4, CD8, and CD19. (a) Depicts representative dot plots from one of eight donors, comparing the
percentage of a-NACþ CD14þ cells of gated monocytes without and with a-NAC incubation. (b–e) PBMCs and isolated monocytes from the same healthy
donors were stimulated with a-NAC (2.5mg/ml), IL-2 (50 U/ml), or a combination of both for 72 hours (b, d) or 8 hours (c, e). Supernatants were measured for levels
of cytokines by ELISA (b, d). Relative levels of mRNA were determined by reverse transcriptase quantitative PCR and normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA (c, e). In d and e, PBMCs are represented by black dots and monocytes by open dots. Medians are shown. *Po0.05, **Po0.01.
(f) Isolated monocytes were stimulated with a-NAC (2.5mg/ml), IL-2 (50 U/ml), or a combination of both for 30 minutes. Western blots for Phospho-p44/42 or
Phospho-NF-kB and GAPDH were performed. One representative experiment of 10 independent experiments is shown.
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Figure 2. a-NAC (the alpha-chain of the nascent polypeptide–associated complex)-induced IL-12 is required for IFN-c secretion in peripheral blood
mononuclear cells (PBMCs). (a) Human PBMCs from eight different donors were preincubated with a blocking antibody against IL-12 p40 (10mg/ml) or the
respective isotype control and then stimulated with a-NAC (2.5mg/ml), IL-2 (50U/ml), or a combination of both for 2 days. Medians are shown. (b) Human PBMCs
from 11 different donors and purified CD4þ T cells from the same donor were stimulated with a-NAC (2.5mg/ml) and IL-2 (50U/ml) for 3 days. Supernatants from
both a and b were collected, and IFN-g secretion was detected using a sandwich ELISA. **Po0.01. PBMCs (c) or monocytes (d) were preincubated with
8mg/ml TLR-2-blocking antibody or the respective isotype control for 30 minutes and then stimulated with a-NAC (2.5mg/ml), IL-2 (50 U/ml), or a combination of
both for 72 hours. Supernatants were measured for levels of IL-12 p40, IFN-g, and IL-6 by ELISA. Isolated monocytes were treated for 3 days with 1mM small
interfering RNA (siRNA; smart-Pool TLR-2 or nontargeting pool as control) and later stimulated with a-NAC (2.5mg/ml) for 3 more days. At day 6, cells were
analyzed by FACS for surface expression of CD14 and TLR-2 (e). Supernatants were taken and measured for levels of IL-12 p40 (f). Medians are shown. *Po0.05,
**Po0.01, ***Po0.001.
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The effect of TLR-2 blockade not only
on secretion of IL-12 p40 and IL-6 but
also on IFN-g might again reflect the
IL-12 dependence of a-NAC-induced
IFN-g secretion. Additionally, in
a-NAC-stimulated monocytes, p44/42
(Erk) and NF-kB were phosphorylated,
both of which are downstream of TLR-2.
A similar phosphorylation pattern and
TLR-2 dependence has been shown for
bacterial HSP-60 and human monocytes
(Zhao et al., 2007). More evidence
comes from the receptor itself: surface
levels of TLR-2 were higher in a-NAC-
treated cells than in controls, suggesting
that a-NAC upregulates its own receptor
as it has been shown for other TLR-2
ligands (Chamorro et al., 2009; Niebuhr
et al., 2009). These data suggest
that TLR-2 is a monocyte receptor for
a-NAC. Nevertheless, TLR-2 may act in
concert with other receptors, as
blockade of TLR-2 did not completely
block the effects of a-NAC.
This is the first report that describes
a nonenzymatic autoantigen capable
of mediating specific IgE and T cell
responses relevant in AD, which also
possesses intrinsic immunomodulatory
potential. Our results clearly demonstrate
that a-NAC is a potent inducer of a
Th1 response in human PBMCs via the
induction of IL-12, and that the mono-
cyte is the primary target cell for a-NAC.
This monocyte activation seems to
depend on the interaction of a-NAC
and TLR-2. Moreover, our data suggest
that a-NAC-activated monocytes could
be particularly efficient in priming
and maintaining an exaggerated Th1
response.
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TO THE EDITOR
We have read with interest the article by
Fitz-Gibbon et al. (2013), which reports
that different Propionibacterium acnes
strain populations exist in acne in
comparison with normal skin. Previous
studies have, indeed, suggested that
globally disseminated clonal lineages
within the P. acnes type IA1 division
may have an etiological role in acne,
whereas other lineages may be asso-
ciated with health (Lomholt and Kilian,
2010; McDowell et al., 2012). If
confirmed, this observation may lead
to a better understanding of acne patho-
genesis and, potentially, new thera-
peutic strategies. There are, however,
major limitations in their study design
related to: (i) skin sampling methodo-
logy, (ii) choice of anatomical site forAccepted article preview online 8 March 2013; published online 4 April 2013
OA Alexeyev and CC Zouboulis
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